Deva Chan,Jun Li,Anna H.K. Plaas,Daniel Predescu,John D. Sandy
申请号:
US15512325
公开号:
US20170266168A1
申请日:
2015.09.14
申请国别(地区):
US
年份:
2017
代理人:
摘要:
One aspect of the invention provides a method for treating or preventing the development of osteoarthritis by administering to a subject in need of such treatment a composition including a therapeutically effective amount of an anti-fibrotic agent. In various embodiments, the anti-fibrotic agent is 5-methyl-1-phenylpyridin-2-one, tranilast, gamma-glutamyl transpeptidase inhibitor, fasudil, CC-930, T-5524, rosiglitazone, tocilizumab, E5564, TAK-242, GKT136901 or bosentan.